Vanda Pharmaceuticals Target of Unusually High Options Trading (VNDA)
Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) was the recipient of some unusual options trading on Thursday. Stock traders bought 11,326 put options on the stock, Analyst Ratings Net reports. This represents an increase of approximately 306% compared to the average volume of 2,787 put options.
Separately, analysts at Lazard Capital Markets reiterated a “buy” rating on shares of Vanda Pharmaceuticals in a research note to investors on Monday, October 21st. They now have a $22.00 price target on the stock. Four equities research analysts have rated the stock with a buy rating, Vanda Pharmaceuticals presently has a consensus rating of “Buy” and an average target price of $16.20.
Vanda Pharmaceuticals (NASDAQ:VNDA) traded up 6.23% on Thursday, hitting $7.16. 2,398,213 shares of the company’s stock traded hands. Vanda Pharmaceuticals has a 1-year low of $2.92 and a 1-year high of $13.30. The stock has a 50-day moving average of $10.36 and a 200-day moving average of $9.13. The company’s market cap is $203.9 million.
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.